Carvedilol inhibits platelet-derived growth factor-induced signal transduction in human cardiac fibroblasts.


In the current study, first the platelet-derived growth factor (PDGF)-induced stimulation of the PDGF-beta receptor kinase in human cardiac fibroblasts was examined, and then the possibility of counterbalancing this signal transduction by carvedilol, a beta-blocker with alpha1-blocking properties, was investigated. Human cardiac fibroblasts were cultured… (More)


  • Presentations referencing similar topics